Medical Discovery NewsBridging the World of Medical Discovery and You

Recent Episodes

New Hope for MS

MP3 WAV

  • During the 2012 U.S. presidential campaign, we learned that Ann Romney, wife of the Republican candidate, had a flare up of her multiple sclerosis or MS. It forced her to cut back her campaign efforts.

    It also spotlighted the disease which is the most common nervous disorder in the U.S. and is caused by an autoimmune response. That's when the body's immune system attacks itself, in particular the myelin sheath covering parts of a nerve cell. We don't know what causes MS, but it is progressive and can impede functions such as walking, vision, and bowel movements.

    Now researchers believe a new MS drug tones down the autoimmune response. The drug, daclizumab, decreases a unique type of immune cell that normally promotes lymph node development in the fetus, but may now be connected to MS. The cells, lymphoid tissue inducer cells or LTi cells, decreased when patients took daclizumab.

    They also had less inflammation in the fluid surrounding the brain and spinal column. The drug lowers inflammation by blocking a molecule called interleukin-two, and activates natural killer cells that also help suppress the immune response.

    From the study's results, researchers believe that by blocking interleukin-two, daclizumab may be acting on a type of stem cell. This encourages the stem cells to produce more natural killer cells than LTi cells, reducing inflammation and the damage that happens in MS.

    More studies will have to confirm the role of LTi cells in MS. Developing drugs to target them will do even more to slow the progression of this disease.

More Information

NIH researchers implicate unique cell type in multiple sclerosis
"Researchers at the National Institutes of Health have found evidence that a unique type of immune cell contributes to multiple sclerosis (MS). Their discovery helps define the effects of one of the newest drugs under investigation for treating MS ' daclizumab ' and could lead to a new class of drugs for treating MS and other autoimmune disorders."

Multiple sclerosis
Lots of information on MS from PubMed Health.

National Multiple Sclerosis Society
Excellent resource for MS info and support.

Atlas of MS Database
"For the first time, information and data on the epidemiology of MS and the availability and accessibility of resources to diagnose, inform, treat, support, manage and rehabilitate people with MS worldwide are available in one database for analysis and comparison at country, regional, and global levels."

Two individuals wearing headphones stand in a recording booth, speaking into microphones with a music stand holding printed pages between them.

 Medicine...

Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.

Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.

No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.

Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.

Podcasts

Alternatively, you can copy and paste the following web address (URL) into iTunes as a new subscription:
https://www.medicaldiscoverynews.com/shows/audio/mdnews.rss

You can also search and subscribe to "Medical Discovery News" in the podcast section of iTunes.

The www.medicaldiscoverynews.com web site and Medical Discovery News radio program (Program) are made possible by The University of Texas Medical Branch at Galveston (UTMB)as a community service and are intended to advance UTMB's mission of providing scholarly teaching, innovative scientific investigation, and state-of-the-art patient care in a learning environment to better the health of society and its commitment to the discovery of new innovative biomedical and health services knowledge leading to increasingly effective and accessible health care for the citizens of Texas.

All information provided on the web site and in the Program is for informational purposes only and is not intended for use as diagnosis or treatment of a health problem or as a substitute for consulting a licensed medical professional. Any information obtained by participating as a web site visitor or program listener is not intended to and should not be considered to constitute medical advice.

Thoughts and opinions expressed on the Program or on the website are those of the authors or guests and do not necessarily reflect the opinions of UTMB. The provision of links to other websites is not to be construed as written or implied sponsorship or endorsement of such websites by UTMB.

Please contact Dr. David Niesel or Dr. Norbert Herzog via email with any concerns, suggestions or comments.

All rights are reserved to information provided on the website or other information sources. No part of these programs can be reproduced stored in a retrieval system or transcribed in any form or by any means for personal or financial gained without the express written permission of Drs. Niesel and Dr. Herzog.